Muscle relaxation properties in myopathies with positive muscle phenomena: a study using transcranial magnetic stimulation

Muscle relaxation properties in myopathies with positive muscle phenomena: a study using transcranial magnetic stimulation - Muscle relaxation in myopathies with positive muscle phenomena

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43031

Enrollment

Registered

2016-06-29

Start date

2017-01-05

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle disorder Myopathies

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosis of one of the following myopathies: - Nemaline myopathy type 6 (NEM6) - Ryanodine receptor type 1 related myopathy (RYR1) - Myotonic dystrophy type 2 (DM2) - Mitochondrial myopathy - McArdle disease - Facioscapulohumeral muscular dystrophy (FSHD)

Exclusion criteria

Exclusion criteria: Age

Design outcomes

Primary

Measure	Time frame
Peak relaxation rate normalized for force Relaxation times: 0.9RT, 0.75RT, 0.50RT, 0.25RT E.g. 0.50RT is the time needed for force to drop from 100% to 50% of maximal force	—

Secondary

Measure	Time frame
Maximal force of fingerflexors	—

Countries

Netherlands

Outcome results